New York Oncology Hematology, P.C., (NYOH) is the Capital Region’s leading provider of community-based cancer care services.
Over the course of more than three decades, New York Oncology Hematology has developed into a cohesive network that provides a comprehensive array of cancer care services including many of the region’s most advanced diagnostic and treatment modalities.
The NYOH medical staff includes 35 board certified physicians who specialize in the care of patients with cancer (medical oncology and radiation oncology) and blood-related disorders (hematology). With a patient care team of more than 300 oncology certified nurses, pharmacists, laboratory technologists, radiation therapists and support personnel and seven, easy-access locations, NYOH is renowned as the cancer care provider of choice for thousands of area residents.
Through its affiliation with The US Oncology Network, one of the nation’s foremost cancer treatment and research networks, NYOH is on the front lines of the latest breakthroughs, cutting-edge treatments and state-of-the-art technologies.
For its highly acclaimed role in cancer research and in the development of dozens of new cancer fighting drugs, New York Oncology Hematology has been honored with the prestigious ASCO (American Society of Clinical Oncology) Community Research Award.
The physicians and staff of New York Oncology Hematology are committed to reducing the incidence of cancer through earlier detection and intervention, achieving more cures and helping patients and their families live well, with cancer.